| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/05/1989 | EP0322786A2 Extraction of process chemicals from labile biological mixtures with halogenated hydrocarbons |
| 07/05/1989 | EP0322717A2 Dactylocycline A and dactylocycline B |
| 07/05/1989 | EP0322425A1 Process for preparing oil composition |
| 07/04/1989 | US4845080 Human calcitonin peptide with salmon calcitonin-like characteristics |
| 07/04/1989 | US4845078 Method for treating hematopoietic diseases |
| 07/04/1989 | US4845075 Biologically active B-chain homodimers |
| 07/04/1989 | US4845037 Biosynthesis with micromonospora |
| 07/04/1989 | US4844895 Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses |
| 07/04/1989 | US4844894 Monophosphoryl lipid a |
| 07/04/1989 | US4844893 Antitumor agents |
| 06/29/1989 | WO1989005849A1 Lactic acid bacteria for use in fermented milk products and veterinary compositions |
| 06/29/1989 | WO1989005657A1 Lymphokine activation of cells for adoptive immunotherapy, e.g. of hiv infection |
| 06/29/1989 | WO1989005651A1 Therapeutical compositions against psoriasis |
| 06/29/1989 | WO1989005650A2 Chemical process |
| 06/28/1989 | EP0322240A2 Chimeric immunocompromised mammals and their use |
| 06/28/1989 | EP0322115A2 Genetic detoxification of pertussis toxin |
| 06/28/1989 | EP0321597A1 Selective adsorbent for binding low-density lipoproteins |
| 06/28/1989 | EP0321545A1 Human epithelium originating from cell cultures |
| 06/27/1989 | US4843065 Supplying killed microorganism vaccine during lactation |
| 06/27/1989 | US4843063 Osteoporosis |
| 06/27/1989 | US4843004 Method for the production of human T-T cell hybrids and production suppressor factor by human T-T cell hybrids |
| 06/27/1989 | US4842855 Antitumor process using a Brucella abortus preparation |
| 06/27/1989 | EP0309456A4 Process for replicating bone marrow. |
| 06/22/1989 | DE3742139A1 Praeparat zur physiologischen regulierung des neuroendokrinen systems, stimulierung der immunitat, wachstumshemmung von hormonabhaengigen geschwulsten und verfahren zur herstellug des genannten praeparates Of preparation for the physiological regulation of the neuroendocrine system, stimulation of immunity, growth inhibition of tumors hormonabhaengigen and process for the preparation of said herstellug |
| 06/21/1989 | EP0320528A1 Use of hemocyanins and arylphorins for influencing the immune system and the treatment of tumors |
| 06/20/1989 | US4840896 Human fertility hormones rna encoding by vectors |
| 06/20/1989 | CA1256027A1 Fibrinophilic urokinase complex and method for production thereof |
| 06/20/1989 | CA1256026A1 Gamma interferon--interleukin-2 synergism |
| 06/15/1989 | WO1989005351A2 Human fc-gamma receptor |
| 06/15/1989 | WO1989005349A1 Method of combating viral infections |
| 06/15/1989 | WO1989005345A1 Genetic modification of endothelial cells |
| 06/15/1989 | WO1989005343A1 Process for producing syngeneic cells, and their use |
| 06/14/1989 | EP0320164A2 Method for preparing hylan and novel hylan product |
| 06/14/1989 | EP0320130A2 Fungicidal active principles, fungicidal compositions, methods of combating fungi, processes of preparing fungicidal active principles, a fungus and fungicidal additives |
| 06/14/1989 | EP0319961A2 Removal method of granulocytes from blood and granulocyte removing apparatus therefor |
| 06/14/1989 | EP0319890A1 A process for the preparation of monosialoganglioside |
| 06/14/1989 | CN1033351A Processing technology and equipment of pilose antler |
| 06/13/1989 | US4839466 For analysis and treatment of diabetic disorders |
| 06/13/1989 | US4839290 Antitumor immunocytes |
| 06/13/1989 | US4839281 Lactobacillus strains and methods of selection |
| 06/13/1989 | US4839172 Composition of accelerating recovery of function of hematopoietic organs |
| 06/13/1989 | US4838852 Contacting with antigen, withdrawal blood, irradiating, returning to patient |
| 06/13/1989 | CA1255591A1 Saccharide digestion inhibiting composition |
| 06/08/1989 | DE3821922A1 Pharmaceutical foodstuff for curative purposes and process for its production |
| 06/08/1989 | DE3741606C1 Verfahren zur Erzeugung syngener Zellen und deren Verwendung A method for generating syngeneic cells and their use |
| 06/07/1989 | EP0319307A2 Human Fc-gamma receptor |
| 06/06/1989 | US4836928 Separation method, separation device and separation apparatus for separating body fluid into respective components |
| 06/06/1989 | CA1255197A1 Leukocyte differentiation composition and method |
| 06/01/1989 | WO1989004821A1 N-(biphenylmethyl)-3-hydroxyglutaramic acid and derivatives as hypocholesterolemic agents |
| 06/01/1989 | WO1989004675A1 Selective removal of immune complexes |
| 06/01/1989 | WO1989004655A1 In vivo delivery of neurotransmitters by implanted, encapsulated cells |
| 06/01/1989 | DE3837669A1 Die verwendung koerpereigener fibroblasten und epidermiszellen als wirkstoff-traeger fuer die intrakorporale behandlung und als wirkstoffvermittler fuer die lokalbehandlung The use koerpereigener fibroblasts and epidermal cells as drug carriers for intracorporeal treatment and drug as intermediaries for the local treatment |
| 06/01/1989 | DE3832578A1 Pharmaceutical for controlling HIV virus infection |
| 05/31/1989 | EP0318181A2 N-(Biphenylmethyl)-3-hydroxyglutaramic acids and derivatives as hypocholesterolemic agents |
| 05/31/1989 | EP0318030A1 Glycoprotein, preparation method, pharmaceutical compositions comprising it and use |
| 05/31/1989 | CN1033154A Eyedrops |
| 05/30/1989 | US4835287 Antibiotic substance |
| 05/30/1989 | US4834890 Centrifugation pheresis system |
| 05/30/1989 | CA1254838A1 Prolonged storage of red blood cells |
| 05/24/1989 | EP0317376A1 Preparation of a concentrate of high-purity human factor IX and of other plasma proteins |
| 05/24/1989 | EP0317355A2 Dietary compositions and methods using bile salt-activated lipase |
| 05/24/1989 | EP0317141A2 Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells |
| 05/24/1989 | EP0317085A2 Processed red blood cells and process for producing the same |
| 05/23/1989 | US4833165 Method of inactivating HTLV-III virus in blood |
| 05/23/1989 | US4833127 Novel CSF and method for obtaining the same |
| 05/23/1989 | US4833074 Purified human granylocyte L1 proteins methods for their preparation, monospecific antibodies and test kits |
| 05/23/1989 | US4832940 Method of locating or imaging activated T-lymphocytes with a targeting polypeptide |
| 05/23/1989 | US4832849 Liquid chromatography |
| 05/23/1989 | CA1254528A1 Process for encapsulation and encapsulated active material system |
| 05/23/1989 | CA1254527A1 Expression vectors for enhanced production of polypeptides, plasmids containing the vectors, hosts containing the plasmids, products manufactured thereby and related methods |
| 05/18/1989 | WO1989004171A1 Protein fraction with immunosuppressive activity, isolated from human seminal plasma |
| 05/18/1989 | WO1989004168A1 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
| 05/17/1989 | EP0315968A1 Plasma and recombinant protein formulations in low ionic strength media |
| 05/17/1989 | EP0315627A1 A method to treat blood. |
| 05/17/1989 | CN1032903A Processing method for synthesized therapeutic mineral water mud and powder |
| 05/16/1989 | US4831120 Method for recovering a purified animal growth hormone or polypeptide analog thereof from a bacterial cell |
| 05/16/1989 | US4831119 Blood clotting factors |
| 05/16/1989 | US4831021 Ganglioside derivatives |
| 05/16/1989 | US4831015 High potency biomass-free avoparcin and a method for its preparation |
| 05/10/1989 | EP0315591A2 Physiologically active substances, a process for the preparation thereof and pharmaceutical compositions containing them |
| 05/10/1989 | EP0315552A1 Galenical forms of quail eggs for per- and sublingual administration in the treatment of allergic diseases, and their preparation process |
| 05/10/1989 | EP0314746A1 Structure for including active substances |
| 05/10/1989 | EP0172873B1 An erection and fertility promoting agent, a method for producing the same, and the use thereof in the production of erection and fertility promoting compositions |
| 05/10/1989 | EP0116579B1 Anti wrinkle implant |
| 05/09/1989 | US4829000 Cell growth, differentiation; protein extract of laminin, collagen, heparin sulfate glycoprotein, entactin, nidogen |
| 05/09/1989 | US4828976 Glucose free media for storing blood platelets |
| 05/09/1989 | US4828821 Glycoprotein, calcium salt crystal growth inhibitor |
| 05/09/1989 | CA1253820A1 Cl-1577-b.sub.4 compound, its production and use |
| 05/09/1989 | CA1253804A1 Cellular viral inhibitor composition |
| 05/09/1989 | CA1253801A1 Substitute for human blood and method of making the same |
| 05/09/1989 | CA1253800A1 Human suppressor factor(s) and method |
| 05/05/1989 | WO1989003875A1 Method of reendothelializing vascular linings |
| 05/05/1989 | WO1989003836A1 Factors associated with essential hypertension |
| 05/05/1989 | WO1989003717A1 Device and method for depletion of the leukocyte content of blood and blood components |
| 05/03/1989 | EP0314401A2 New compound WF 2015 A and B, production thereof and use thereof |
| 05/03/1989 | EP0314095A1 Plasma and recombinant protein formulation in high ionic strength media |
| 05/03/1989 | EP0313846A2 Method for controlling chronic respiratory disease, and necrotic enteritis in avian species |
| 05/03/1989 | EP0313808A2 Synthetic, plasma-free, transfusible storage medium for red blood cells |
| 05/03/1989 | EP0313718A2 Process for the fractionation of huminates |
| 05/03/1989 | DE3836006A1 Monophosphoryllipid-a-derivate und verfahren zu deren herstellung Monophosphoryl lipid A derivatives and methods for their preparation |